nivolumab,ipilimumab
ono Pharmaceuticals,bms
['nivo', 'nivolumab', 'bcsm', 'ipilimumab', 'tnbc', 'bellini', 'breast']
just in: nivolumab and ipilimumab in
early-stage triple negative breast
cancer with tumor-infiltrating
lymphocytes: first results from
the bellini trial at #esmo22 presented by dr. marleen kok #bcsm #talktnbc 
MD, PhD, Medical Oncologist, interests #breastcancer #bcsm #gyncsm #ImmunoOnc #Immunotherapy #biomarkers #clinicaltrials @ASCO Views my own.